CN103876352B - Knee braces for knee arthritis - Google Patents
Knee braces for knee arthritis Download PDFInfo
- Publication number
- CN103876352B CN103876352B CN201410080380.4A CN201410080380A CN103876352B CN 103876352 B CN103876352 B CN 103876352B CN 201410080380 A CN201410080380 A CN 201410080380A CN 103876352 B CN103876352 B CN 103876352B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- borneol
- knee
- chinese gall
- purslane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及保健品技术领域,尤其涉及一种用于治疗膝关节炎的护膝。The invention relates to the technical field of health care products, in particular to a knee pad for treating knee arthritis.
背景技术Background technique
膝关节炎又称为退行性膝关节炎、增生性膝关节炎等,是中老年人的常见疾病,属于中医"痹症"范畴。主要表现为关节疼痛、僵硬、功能障碍,除此之外还可出现社会活动能力低下及心理功能异常,最终导致生活质量下降。流行病学调查示,55岁以上中老年人大约10人中就有4-7人患此病,其中十分之一有各种功能障碍表现。其发病比较隐蔽,病程相当长,致残率较高,严重危害人类身体健康,已成为人类50岁以后丧失劳动力的第二个常见原因。根据世界卫生组织(WHO)统计分析,目前全球人口中,医疗行为中的十分之一与膝关节炎相关。随着人口老年化趋势,现起往后的未来10年内超过50岁的老年人将成倍增长,患病人数还将大幅增多,在世界范围内因膝关节炎带来的医疗负担将剧增,与此同时患者功能丧失及劳动力丧失所带来的社会生产力的下降及损失,另外其他相关的额外经济负担也急剧增加。Knee arthritis, also known as degenerative knee arthritis, proliferative knee arthritis, etc., is a common disease of middle-aged and elderly people, and belongs to the category of "arthritis" in traditional Chinese medicine. The main manifestations are joint pain, stiffness, and functional impairment. In addition, low social mobility and abnormal psychological function can also occur, which ultimately leads to a decline in quality of life. Epidemiological surveys show that about 4-7 out of 10 middle-aged and elderly people over the age of 55 suffer from this disease, and one tenth of them has various dysfunctions. Its onset is relatively hidden, the course of the disease is quite long, the disability rate is high, and it seriously endangers human health. It has become the second common cause of human loss of labor force after the age of 50. According to the statistical analysis of the World Health Organization (WHO), in the current global population, one tenth of the medical behavior is related to knee arthritis. With the trend of population aging, the number of elderly people over 50 years old will double in the next 10 years, and the number of patients will increase significantly. The medical burden caused by knee arthritis will increase sharply worldwide. At the same time, the decline and loss of social productivity caused by the loss of patient function and labor force, and other related additional economic burdens have also increased sharply.
膝关节炎综合治疗方案包括三方面:非药物治疗和药物治疗,根据病情需要,必要时考虑手术治疗。非甾体抗炎止痛药、软骨生物活性药是西医治疗的用药主体,然而到目前为止除手术外尚无根治的方法,这些治疗往往疗程长,给病人带来了很大的经济负担,且副作用多,如手术治疗会给患者带来一定痛苦,且易出现感染、血管损伤、神经损伤、皮肤坏死、骨坏死、髌骨低位、关节活动受限等不良并发症,故简单快速安全且有效的治疗方法是广大膝关节炎患者的迫切需要。The comprehensive treatment plan for knee arthritis includes three aspects: non-drug treatment and drug treatment. According to the needs of the condition, surgical treatment should be considered if necessary. Non-steroidal anti-inflammatory analgesics and cartilage bioactive drugs are the main medications of Western medicine. However, so far there is no radical cure except surgery. These treatments often have a long course of treatment, which brings a great economic burden to patients. There are many side effects, such as surgical treatment will bring some pain to the patient, and it is prone to adverse complications such as infection, vascular injury, nerve injury, skin necrosis, bone necrosis, low patella, and limited joint mobility, so it is simple, fast, safe and effective. Therapeutic method is the urgent need of vast knee arthritis patient.
中医认为膝关节炎属于中医“痹症”范围,病因主要为年老体虚、关节损伤、环境等因素导致肝肾亏损,肝肾与筋骨的关系密切,由于肝主筋、肾主骨,肝血虚不能荣养筋络、肾精亏损不能充养骨髓,风寒湿邪乘虚侵袭膝关节而发病。中医药治疗有其独特的的优势,膝骨关节疾病的特点是关节局部症状明显,经络气血不贯、筋骨不和而有定位,针对关节局部的外治法常可获效。其简单易行,针对疼痛等症状改善显著,且使用外用治法毒副作用较小,也不会增加肝肾器官的毒性作用,安全性高,经济实用。Traditional Chinese medicine believes that knee arthritis belongs to the scope of "arthritis" in traditional Chinese medicine. The main cause is the loss of liver and kidney caused by old age, physical weakness, joint damage, and environmental factors. Unable to prosper and nourish the tendons and collaterals, the deficiency of kidney essence cannot replenish and nourish the bone marrow, and the wind-cold-damp evil takes advantage of the deficiency to invade the knee joint and cause the disease. Chinese medicine treatment has its unique advantages. Knee osteoarthritis is characterized by obvious local symptoms, incoherent Qi and blood in the meridians, disharmony of muscles and bones, and localization. External treatment for local joints can often be effective. It is simple and easy to implement, can significantly improve symptoms such as pain, and has less toxic and side effects when used for external use, and will not increase the toxic effects of liver and kidney organs, and is highly safe, economical and practical.
本发明就是在中医理论的基础上提出一种用于治疗膝关节炎的中药以及采用该中药制备而成的护膝,从而对膝关节炎具有很好的治疗效果,无毒副作用,安全性高,经济实用。The present invention proposes a traditional Chinese medicine for treating knee arthritis and a knee protector prepared by using the traditional Chinese medicine on the basis of the theory of traditional Chinese medicine, so that it has a good therapeutic effect on knee arthritis, has no toxic and side effects, and has high safety. Economical and practical.
发明内容Contents of the invention
本发明所要解决的技术问题是提供一种用于治疗膝关节炎的中药以及采用该中药制备而成的护膝,从而对膝关节炎具有很好的治疗效果,无毒副作用,安全性高,经济实用。The technical problem to be solved by the present invention is to provide a kind of traditional Chinese medicine for treating knee arthritis and a knee protector prepared by using the traditional Chinese medicine, so that it has a good therapeutic effect on knee arthritis, has no toxic and side effects, high safety, and is economical. practical.
为解决上述技术问题,本发明提供了一种用于治疗膝关节炎的护膝,其包括外保护层、发热层、用于治疗膝关节的中药组合物细粉夹层和内层衬垫层,所述中药组合物细粉采用布袋进行包裹,放置于外保护层和内层衬垫层作为夹层使用。In order to solve the above technical problems, the present invention provides a knee pad for treating knee arthritis, which includes an outer protective layer, a heating layer, a Chinese medicine composition fine powder interlayer for treating knee joints, and an inner liner layer. The fine powder of the traditional Chinese medicine composition is wrapped in a cloth bag, placed on the outer protective layer and the inner liner layer and used as an interlayer.
其中,所述中药组合物细粉的原料药包括肉苁蓉、茜草、三七、巴戟天、当归、杜仲、芸香草、鹿衔草、五倍子、绞股蓝、栀子、桑寄生、透骨草、羌活、川牛膝、刺五加、补骨脂、五倍子、卷柏、没药、藏菖蒲、肿节风、马齿苋、接骨草、薏苡仁和冰片。Wherein, the raw materials of the fine powder of the traditional Chinese medicine composition include cistanche, madder, notoginseng, morinda officinalis, angelica, eucommia, rue, chrysanthemum, gall, gynostemma, gardenia, mulberry, togucao, notopterygium , Sichuan Achyranthes bidentata, Acanthopanax, Psoralen, gallnut, Selaginella, myrrh, Tibetan calamus, sarcocarpus, purslane, elderberry, coix seed and borneol.
其中,所述各原料药的重量分别为肉苁蓉35g~45g、茜草30g~40g、三七40g~50g、巴戟天25g~35g、当归35g~45g、杜仲15g~25g、芸香草15g~25g、鹿衔草20g~30g、五倍子35g~45g、绞股蓝25g~35g、栀子10g~20g、桑寄生20g~30g、透骨草15g~25g、羌活15g~25g、川牛膝20g~30g、刺五加25g~35g、补骨脂20g~30g、五倍子35g~45g、卷柏35g~45g、没药20g~30g、藏菖蒲15g~25g、肿节风15g~25g、马齿苋10g~20g、接骨草15g~25g、薏苡仁20g~30g和冰片25g~35g。Wherein, the weights of each raw material drug are respectively 35g-45g of Cistanche, 30g-40g of Rubia, 40g-50g of Panax notoginseng, 25g-35g of Morinda officinalis, 35g-45g of angelica, 15g-25g of Eucommia, 15g-25g of rue, 20g-30g of Luniancao, 35g-45g of Chinese gall, 25g-35g of Gynostemma, 10g-20g of gardenia, 20g-30g of mulberry, 15g-25g of Speranthema, 15g-25g of Notopterygium, 20g-30g of Achyranthes achyranthes, Acanthopanax five Add 25g~35g, psoralen 20g~30g, gallnut 35g~45g, selaginella 35g~45g, myrrh 20g~30g, Tibetan calamus 15g~25g, sarcocarpus 15g~25g, purslane 10g~20g, bone marrow Grass 15g~25g, coix seed 20g~30g and borneol 25g~35g.
其中,所述中药中各原料药的重量分别为肉苁蓉37g~43g、茜草32g~38g、三七42g~48g、巴戟天27g~33g、当归37g~43g、杜仲17g~23g、芸香草17g~23g、鹿衔草22g~28g、五倍子37g~43g、绞股蓝28g~33g、栀子12g~18g、桑寄生22g~28g、透骨草18g~23g、羌活17g~23g、川牛膝22g~28g、刺五加27g~33g、补骨脂22g~28g、五倍子37g~43g、卷柏37g~43g、没药22g~28g、藏菖蒲17g~23g、肿节风17g~23g、马齿苋12g~18g、接骨草17g~23g、薏苡仁22g~28g和冰片27g~33g。Wherein, the weights of the raw materials in the traditional Chinese medicine are 37g-43g of Cistanche, 32g-38g of Rubia, 42g-48g of Panax notoginseng, 27g-33g of Morinda officinalis, 37g-43g of Angelica sinensis, 17g-23g of Eucommia ulmoides, 17g-23g of rue 23g, 22g-28g of Luniancao, 37g-43g of Chinese gall, 28g-33g of Gynostemma, 12g-18g of gardenia, 22g-28g of mulberry, 18g-23g of Speranthema, 17g-23g of Notopterygium, 22g-28g of Achyranthes bidentata, Acanthopanax 27g~33g, psoralen 22g~28g, Galla chinensis 37g~43g, Selaginella 37g~43g, myrrh 22g~28g, Tibetan calamus 17g~23g, sarcocarpus 17g~23g, purslane 12g~18g , elderberry 17g-23g, coix seed 22g-28g and borneol 27g-33g.
其中,所述中药组合物细粉的制备方法具体为:Wherein, the preparation method of the fine powder of the Chinese medicine composition is specifically:
第一步,将冰片研磨成细分,备用;The first step is to grind the ice flakes into subdivisions and set aside;
第二步,将余下的原料药组分按重量混合在一起,获得混合物,每100g混合物加入300g~400g的水,加热煮沸2~3小时,煎煮液过滤,滤渣再次加水,加热煮沸2~3小时,每100g滤渣加入200g~300g的水,煎煮液过滤,与前面的过滤液混合,获得的混合滤液浓缩除去水,获得干膏,粉碎成粉末,与第一步获得的研磨后的冰片混合,再放入超微粉碎机中进一步粉碎成400目的细粉。The second step is to mix the remaining raw material components together by weight to obtain a mixture, add 300g to 400g of water for every 100g of the mixture, heat and boil for 2 to 3 hours, filter the decoction, add water to the filter residue again, and heat and boil for 2 to 3 hours. For 3 hours, add 200g to 300g of water per 100g of filter residue, filter the decoction, mix with the previous filtrate, concentrate the obtained mixed filtrate to remove water, obtain a dry paste, crush it into powder, and mix it with the ground obtained in the first step The ice flakes are mixed, and then put into an ultrafine pulverizer and further pulverized into a 400-mesh fine powder.
本发明还提供了一种用于治疗膝关节炎的中药,其原料药包括肉苁蓉、茜草、三七、巴戟天、当归、杜仲、芸香草、鹿衔草、五倍子、绞股蓝、栀子、桑寄生、透骨草、羌活、川牛膝、刺五加、补骨脂、五倍子、卷柏、没药、藏菖蒲、肿节风、马齿苋、接骨草、薏苡仁和冰片。The present invention also provides a traditional Chinese medicine for treating knee arthritis. Parasitic, Scutellaria, notopterygium, Achyranthes bidentata, eleuthero, psoralen, gallnut, selaginella, myrrh, Tibetan calamus, sarcocarpus, purslane, elderberry, coix seed and borneol.
其中,所述中药中各原料药的重量分别为肉苁蓉37g~43g、茜草32g~38g、三七42g~48g、巴戟天27g~33g、当归37g~43g、杜仲17g~23g、芸香草17g~23g、鹿衔草22g~28g、五倍子37g~43g、绞股蓝28g~33g、栀子12g~18g、桑寄生22g~28g、透骨草18g~23g、羌活17g~23g、川牛膝22g~28g、刺五加27g~33g、补骨脂22g~28g、五倍子37g~43g、卷柏37g~43g、没药22g~28g、藏菖蒲17g~23g、肿节风17g~23g、马齿苋12g~18g、接骨草17g~23g、薏苡仁22g~28g和冰片27g~33g。Wherein, the weights of the raw materials in the traditional Chinese medicine are 37g-43g of Cistanche, 32g-38g of Rubia, 42g-48g of Panax notoginseng, 27g-33g of Morinda officinalis, 37g-43g of Angelica sinensis, 17g-23g of Eucommia ulmoides, 17g-23g of rue 23g, 22g-28g of Luniancao, 37g-43g of Chinese gall, 28g-33g of Gynostemma, 12g-18g of gardenia, 22g-28g of mulberry, 18g-23g of Speranthema, 17g-23g of Notopterygium, 22g-28g of Achyranthes bidentata, Acanthopanax 27g~33g, psoralen 22g~28g, Galla chinensis 37g~43g, Selaginella 37g~43g, myrrh 22g~28g, Tibetan calamus 17g~23g, sarcocarpus 17g~23g, purslane 12g~18g , elderberry 17g-23g, coix seed 22g-28g and borneol 27g-33g.
其中,所述中药中各原料药的重量分别为肉苁蓉40g、茜草35g、三七45g、巴戟天30g、当归40g、杜仲20g、芸香草20g、鹿衔草25g、五倍子40g、绞股蓝30g、栀子15g、桑寄生25g、透骨草20g、羌活20g、川牛膝25g、刺五加30g、补骨脂25g、五倍子40g、卷柏40g、没药25g、藏菖蒲20g、肿节风20g、马齿苋15g、接骨草20g、薏苡仁25g和冰片30g。Wherein, the weights of each raw material in the traditional Chinese medicine are 40g of Cistanche, 35g of Rubia, 45g of Panax notoginseng, 30g of Morinda officinalis, 40g of Angelica sinensis, 20g of Eucommia ulmoides, 20g of rue herb, 25g of deer nigra, 40g of Galla chinensis, 30g of Gynostemma pentaphyllum, 15g mulberry, 25g Selaginella, 20g Speranthum, 20g notopterygium, 25g Achyranthes achyranthes, 30g Acanthopanax, 25g psoralen, 40g Galla chinensis, 40g Selaginella, 25g myrrh, 20g Tibetan calamus, 20g sarcophagus, Purslane 15g, elderberry 20g, coix seed 25g and borneol 30g.
本发明还提供了上述中药组合物的制备方法:The present invention also provides the preparation method of above-mentioned Chinese medicine composition:
第一步,将冰片研磨成细分,备用;The first step is to grind the ice flakes into subdivisions and set aside;
第二步,将余下的原料药组分按重量混合在一起,获得混合物,每100g混合物加入300g~400g的水,加热煮沸2~3小时,煎煮液过滤,滤渣再次加水,加热煮沸2~3小时,每100g滤渣加入200g~300g的水,煎煮液过滤,与前面的过滤液混合,获得的混合滤液浓缩除去水,获得干膏,粉碎成粉末,与第一步获得的研磨后的冰片混合,再放入超微粉碎机中进一步粉碎成400目的细粉。The second step is to mix the remaining raw material components together by weight to obtain a mixture, add 300g to 400g of water for every 100g of the mixture, heat and boil for 2 to 3 hours, filter the decoction, add water to the filter residue again, and heat and boil for 2 to 3 hours. For 3 hours, add 200g to 300g of water per 100g of filter residue, filter the decoction, mix with the previous filtrate, concentrate the obtained mixed filtrate to remove water, obtain a dry paste, crush it into powder, and mix it with the ground obtained in the first step The ice flakes are mixed, and then put into an ultrafine pulverizer and further pulverized into a 400-mesh fine powder.
本发明的有益效果:Beneficial effects of the present invention:
本发明提供的用于治疗膝关节炎的中药以及采用该中药制备而成的护膝,从而对膝关节炎具有很好的治疗效果,无毒副作用,安全性高,经济实用。The traditional Chinese medicine for treating knee arthritis and the knee protector prepared by using the traditional Chinese medicine provided by the invention have a good therapeutic effect on knee arthritis, have no toxic and side effects, are high in safety, and are economical and practical.
具体实施方式Detailed ways
膝关节炎多起病于中老年,由“肝气衰,筋不能动”进而“肾脏衰,形体皆极”,气血亏虚,在体则“筋”“骨”失养,可见“弱而不用”“骨枯而髓虚”:又气血虚衰,血滞经潘,易受风寒湿侵袭或痰瘀留滞经络,气血行更失其畅;发为筋骨之癆,久亦可成痿。本病病因是感受风寒湿邪,或因跌仆损伤,内伤肝肾不足、气血失和。病机是外邪寒湿瘀阻经络,气血运行不畅,络脉痹阻不通。病位在肌肉筋骨,病理因素主要为寒、湿、痰、瘀,病理性质表现为本虚标实,治疗方法为散寒化湿,行气活血,祛瘀通络。Knee arthritis often occurs in middle-aged and elderly people, from "weakness of liver qi, immobility of tendons" to "failure of kidneys, extreme shape", deficiency of qi and blood, and loss of nourishment of "muscles" and "bones" in the body, it can be seen that "weak and weak" Don't use "withered bones and marrow deficiency": Deficiency of qi and blood, blood stagnation in the meridians, easy to be attacked by wind, cold and dampness, or stagnation of phlegm and blood stasis in the meridians, and the flow of qi and blood will be even less smooth; atrophy. The etiology of this disease is the feeling of wind-cold-damp evil, or injury due to falls, internal injury of liver and kidney deficiency, and disharmony of Qi and blood. The pathogenesis is that exogenous evils, cold, dampness and blood stasis block the meridians, the circulation of Qi and blood is not smooth, and the obstruction of the collaterals is blocked. The disease is located in the muscles, tendons and bones, and the pathological factors are mainly cold, dampness, phlegm, and blood stasis. The pathological properties are manifested as deficiency in origin and excess in excess.
本发明提供了一种用于治疗膝关节炎的中药,其原料药包括肉苁蓉、茜草、三七、巴戟天、当归、杜仲、芸香草、鹿衔草、五倍子、绞股蓝、栀子、桑寄生、透骨草、羌活、川牛膝、刺五加、补骨脂、五倍子、卷柏、没药、藏菖蒲、肿节风、马齿苋、接骨草、薏苡仁和冰片。The invention provides a traditional Chinese medicine for treating knee arthritis, the raw materials of which include cistanche, madder, notoginseng, morinda officinalis, angelica, eucommia, rue, chrysanthemum, Galla, gynostemma, gardenia, mulberry , Scutellaria, notopterygium, Achyranthes bidentata, eleuthero, psoralen, gallnut, selaginella, myrrh, Tibetan calamus, sarcophagus, purslane, elderberry, coix seed and borneol.
进一步,所述中药仅由上述原料药构成。Further, the traditional Chinese medicine is only composed of the above raw materials.
所述中药中各原料药的重量分别为肉苁蓉35g~45g、茜草30g~40g、三七40g~50g、巴戟天25g~35g、当归35g~45g、杜仲15g~25g、芸香草15g~25g、鹿衔草20g~30g、五倍子35g~45g、绞股蓝25g~35g、栀子10g~20g、桑寄生20g~30g、透骨草15g~25g、羌活15g~25g、川牛膝20g~30g、刺五加25g~35g、补骨脂20g~30g、五倍子35g~45g、卷柏35g~45g、没药20g~30g、藏菖蒲15g~25g、肿节风15g~25g、马齿苋10g~20g、接骨草15g~25g、薏苡仁20g~30g和冰片25g~35g。The weights of the raw materials in the traditional Chinese medicine are respectively 35g-45g of Cistanche, 30g-40g of Rubia, 40g-50g of Panax notoginseng, 25g-35g of Morinda Citrifolia, 35g-45g of Angelica sinensis, 15g-25g of Eucommia ulmoides, 15g-25g of rue, 20g-30g of Luniancao, 35g-45g of Chinese gall, 25g-35g of Gynostemma, 10g-20g of gardenia, 20g-30g of mulberry, 15g-25g of Speranthema, 15g-25g of Notopterygium, 20g-30g of Achyranthes achyranthes, Acanthopanax five Add 25g~35g, psoralen 20g~30g, gallnut 35g~45g, selaginella 35g~45g, myrrh 20g~30g, Tibetan calamus 15g~25g, sarcocarpus 15g~25g, purslane 10g~20g, bone marrow Grass 15g~25g, coix seed 20g~30g and borneol 25g~35g.
进一步,所述中药中各原料药的重量分别为肉苁蓉37g~43g、茜草32g~38g、三七42g~48g、巴戟天27g~33g、当归37g~43g、杜仲17g~23g、芸香草17g~23g、鹿衔草22g~28g、五倍子37g~43g、绞股蓝28g~33g、栀子12g~18g、桑寄生22g~28g、透骨草18g~23g、羌活17g~23g、川牛膝22g~28g、刺五加27g~33g、补骨脂22g~28g、五倍子37g~43g、卷柏37g~43g、没药22g~28g、藏菖蒲17g~23g、肿节风17g~23g、马齿苋12g~18g、接骨草17g~23g、薏苡仁22g~28g和冰片27g~33g。Further, the weights of the raw materials in the traditional Chinese medicine are 37g-43g of Cistanche, 32g-38g of Rubia, 42g-48g of Panax notoginseng, 27g-33g of Morinda officinalis, 37g-43g of Angelica sinensis, 17g-23g of Eucommia ulmoides, and 17g-48g of rue. 23g, 22g-28g of Luniancao, 37g-43g of Chinese gall, 28g-33g of Gynostemma, 12g-18g of gardenia, 22g-28g of mulberry, 18g-23g of Speranthema, 17g-23g of Notopterygium, 22g-28g of Achyranthes bidentata, Acanthopanax 27g~33g, psoralen 22g~28g, gallnut 37g~43g, selaginella 37g~43g, myrrh 22g~28g, Tibetan calamus 17g~23g, sarcocarpus 17g~23g, purslane 12g~18g , elderberry 17g-23g, coix seed 22g-28g and borneol 27g-33g.
最优选,所述中药中各原料药的重量分别为肉苁蓉40g、茜草35g、三七45g、巴戟天30g、当归40g、杜仲20g、芸香草20g、鹿衔草25g、五倍子40g、绞股蓝30g、栀子15g、桑寄生25g、透骨草20g、羌活20g、川牛膝25g、刺五加30g、补骨脂25g、五倍子40g、卷柏40g、没药25g、藏菖蒲20g、肿节风20g、马齿苋15g、接骨草20g、薏苡仁25g和冰片30g。Most preferably, the weights of the raw materials in the traditional Chinese medicine are respectively 40g of Cistanche, 35g of Rubia, 45g of Radix Notoginseng, 30g of Morinda officinalis, 40g of Angelica sinensis, 20g of Eucommia ulmoides, 20g of Rutaceae, 25g of Cistanche, 40g of Galla chinensis, 30g of Jiaogulan, Gardenia 15g, Sangji 25g, Scutellaria 20g, Notopterygium 20g, Achyranthes bidentata 25g, Acanthopanax 30g, Psoralen 25g, Galla chinensis 40g, Selaginella 40g, Myrrh 25g, Tibetan calamus 20g, Sargassum 20g , purslane 15g, elderberry 20g, coix seed 25g and borneol 30g.
本发明还提供了上述中药组合物的制备方法:The present invention also provides the preparation method of above-mentioned Chinese medicine composition:
第一步,将冰片研磨成细分,备用;The first step is to grind the ice flakes into subdivisions and set aside;
第二步,将余下的原料药组分按重量混合在一起,获得混合物,每100g混合物加入300g~400g的水,加热煮沸2~3小时,煎煮液过滤,滤渣再次加水,加热煮沸2~3小时,每100g滤渣加入200g~300g的水,煎煮液过滤,与前面的过滤液混合,获得的混合滤液浓缩除去水,获得干膏,粉碎成粉末,与第一步获得的研磨后的冰片混合,再放入超微粉碎机中进一步粉碎成400目的细粉。The second step is to mix the remaining raw material components together by weight to obtain a mixture, add 300g to 400g of water for every 100g of the mixture, heat and boil for 2 to 3 hours, filter the decoction, add water to the filter residue again, and heat and boil for 2 to 3 hours. For 3 hours, add 200g to 300g of water per 100g of filter residue, filter the decoction, mix with the previous filtrate, concentrate the obtained mixed filtrate to remove water, obtain a dry paste, crush it into powder, and mix it with the ground obtained in the first step The ice flakes are mixed, and then put into an ultrafine pulverizer and further pulverized into a 400-mesh fine powder.
本发明还提供了一种用于治疗膝关节炎的护膝,其包括外保护层、发热层、中药组合物夹层和内层衬垫层,上述制备的中药组合物细粉采用布袋进行包裹,放置于外保护层和内层衬垫层作为夹层使用。The present invention also provides a knee pad for treating knee arthritis, which includes an outer protective layer, a heating layer, a Chinese medicine composition interlayer and an inner liner layer. The fine powder of the Chinese medicine composition prepared above is wrapped in a cloth bag, placed It is used as a sandwich between the outer protective layer and the inner liner layer.
所述布袋通过无纺布材料布袋织成网状。The cloth bag is woven into a net shape by a non-woven material cloth bag.
所述发热层采用碳纤维发热导电布制备而成,利用发热层的发热特性,可以促进中药组合物的疗效更好,所述发热层还包括锂电池和开关,将碳纤维发热导电布与锂电池和开关相连接,压制在皮层上,构成发热层。The heating layer is made of carbon fiber heating conductive cloth, and the heating characteristics of the heating layer can be used to promote better curative effect of the traditional Chinese medicine composition. The heating layer also includes a lithium battery and a switch, and the carbon fiber heating conductive cloth is combined with the lithium battery and The switches are connected and pressed on the cortex to form the heating layer.
以下采用实施例来详细说明本发明的实施方式,借此对本发明如何应用技术手段来解决技术问题,并达成技术效果的实现过程能充分理解并据以实施。The following examples are used to describe the implementation of the present invention in detail, so as to fully understand and implement the process of how to apply technical means to solve technical problems and achieve technical effects in the present invention.
实施例1中药细粉的制备The preparation of embodiment 1 Chinese medicine fine powder
将冰片30g研磨成细分,备用,将肉苁蓉40g、茜草35g、三七45g、巴戟天30g、当归40g、杜仲20g、芸香草20g、鹿衔草25g、五倍子40g、绞股蓝30g、栀子15g、桑寄生25g、透骨草20g、羌活20g、川牛膝25g、刺五加30g、补骨脂25g、五倍子40g、卷柏40g、没药22g~28g、藏菖蒲20g、肿节风20g、马齿苋15g、接骨草20g、薏苡仁25g混合在一起,获得混合物,每100g混合物加入400g的水,加热煮沸3小时,煎煮液过滤,滤渣再次加水,加热煮沸3小时,每100g滤渣加入300g的水,煎煮液过滤,与前面的过滤液混合,获得的混合滤液浓缩除去水,获得干膏,粉碎成粉末,与前面获得的研磨后的冰片混合,再放入超微粉碎机中进一步粉碎成400目的细粉。Grind 30g of borneol into subdivisions, set aside, 40g of cistanche, 35g of madder, 45g of Panax notoginseng, 30g of Morinda officinalis, 40g of angelica, 20g of Eucommia ulmoides, 20g of rue herb, 25g of cervix, 40g of Chinese gall, 30g of gynostemma, 15g of gardenia , Sangjisheng 25g, Speranthum 20g, Notopterygium 20g, Achyranthes bidentata 25g, Acanthopanax 30g, Psoralen 25g, Galla chinensis 40g, Selaginella 40g, Myrrh 22g~28g, Tibetan calamus 20g, Sarcodon 20g, 15g of purslane, 20g of elderberry, and 25g of coix seed are mixed together to obtain a mixture. Add 400g of water to each 100g of the mixture, heat and boil for 3 hours, filter the decoction, add water to the filter residue, heat and boil for 3 hours, and add 300g of water, filter the decoction, mix with the previous filtrate, concentrate the obtained mixed filtrate to remove water, obtain a dry cream, grind it into powder, mix it with the ground borneol obtained above, and put it into a superfine pulverizer Further crushed into 400 mesh fine powder.
实施例2护膝的制备The preparation of embodiment 2 knee pads
用无纺布材料制成网状布袋,将实施例1制备的中药组合物粉末放置在布袋中,制成中药组合物粉末夹层,将锂电池、开关和碳纤维发热导电布压制在皮层上,构成发热层,将外层保护皮层、发热层、中药组合物粉末夹层和内层棉垫构成的衬垫层缝制在一起,形成护膝。A mesh cloth bag is made of non-woven material, and the powder of the traditional Chinese medicine composition prepared in Example 1 is placed in the cloth bag to form an interlayer of the powder of the Chinese medicine composition, and a lithium battery, a switch, and a carbon fiber heating conductive cloth are pressed on the cortex to form a As for the heating layer, the liner layer composed of the outer protective cortex, the heating layer, the powder interlayer of traditional Chinese medicine composition and the inner cotton pad is sewn together to form the knee pad.
实施例3临床效果Embodiment 3 clinical effect
一般资料normal information
2001年3月~2013年6月根据《中医病证诊疗标准与方剂选用》确诊收治的220例患者。双侧膝关节X线片显示,不同程度关节间隙不对称,软骨下硬化或骨质增生,胫骨或股骨内外髁唇样增生。临床症状:膝关节疼痛,久站、上下楼、下蹲疼痛加重,局部肿胀,部分患者有静息痛、关节腔积液。将上述患者随机分为治疗组和对照组,治疗组120例,男66例,女54例,年龄44~78岁,病程10个月~21年,平均5.3年。对照组100例,男48例,女52例;年龄43~77岁,病程9个月~23年。两组患者年龄、病程、病情比较等一般资料比较,无显著性差异(P>0.05),具有可比性。From March 2001 to June 2013, 220 patients were diagnosed and treated according to the "Standards of Diagnosis and Treatment of Diseases and Syndromes and Selection of Prescriptions in Traditional Chinese Medicine". X-ray films of bilateral knee joints showed varying degrees of joint space asymmetry, subchondral sclerosis or bone hyperplasia, and labial hyperplasia of the tibial or femoral medial and medial condyles. Clinical symptoms: Knee joint pain, aggravated pain when standing for a long time, going up and down stairs, squatting, local swelling, some patients have rest pain, joint cavity effusion. The patients were randomly divided into treatment group and control group. The treatment group consisted of 120 cases, including 66 males and 54 females, aged 44 to 78 years, with a course of disease ranging from 10 months to 21 years, with an average of 5.3 years. The control group consisted of 100 cases, including 48 males and 52 females; aged 43 to 77 years, with a disease course of 9 months to 23 years. There was no significant difference between the two groups in terms of general information such as age, course of disease, and condition comparison (P>0.05), which was comparable.
方法method
对照组行膝关节腔穿刺注射,第1周注入曲安奈德20mg,第2周注入透明质酸钠2mL,曲安奈德和透明质酸钠隔周交替应用,拔针后无菌敷料敷盖,缓慢屈伸关节数次,使药物均匀分布在关节腔内,每周1次,5周为1个疗程。The control group received puncture injection into the knee joint cavity. In the first week, 20 mg of triamcinolone acetonide was injected, and in the second week, 2 mL of sodium hyaluronate was injected. Triamcinolone acetonide and sodium hyaluronate were applied alternately every other week. After the needle was pulled out, a sterile dressing was applied. Slowly flex and extend the joint several times to make the drug evenly distributed in the joint cavity, once a week, 5 weeks as a course of treatment.
治疗组行膝关节腔穿刺注射,第1周注入曲安奈德5mg,第2周注入透明质酸钠1mL,曲安奈德和透明质酸钠隔周交替应用,拔针后无菌敷料敷盖,缓慢屈伸关节数次,使药物均匀分布在关节腔内,每周1次,5周为1个疗程,同时,每日佩戴实施例2制备的护膝,加热护理5~8次,每次20分钟~30分钟。两组患者连服2个疗程后,观察疗效。The treatment group received puncture injection into the knee joint cavity, injected triamcinolone acetonide 5 mg in the first week, and injected sodium hyaluronate 1 mL in the second week. Triamcinolone acetonide and sodium hyaluronate were applied alternately every other week. After the needle was pulled out, a sterile dressing was applied. Slowly flex and extend the joint several times to make the drug evenly distributed in the joint cavity. Once a week, 5 weeks is a course of treatment. At the same time, wear the knee pad prepared in Example 2 every day, and heat nursing 5 to 8 times, 20 minutes each time ~30 minutes. After two courses of treatment, the patients in the two groups were treated to observe the curative effect.
疗效标准Efficacy standard
采用目前在临床运用的较为广泛的Lysholm膝关节功能评分判定对病变膝关节进行评分,疗效标准分为显效、有效和无效。以(显效+有效)/总患者×100%,计算有效率。The Lysholm knee joint function score, which is currently widely used in clinical practice, is used to determine the score of the diseased knee joint. The curative effect standard is divided into markedly effective, effective and ineffective. The effective rate was calculated as (marked effect + effective)/total patients × 100%.
统计学处理statistical processing
采用SPSS12.0统计学软件进行分析,定量资料以表示,行χ2检验,以P<0.05为统计学有差异显著。Statistical software SPSS 12.0 was used for analysis, and the quantitative data were Said, line χ 2 test, with P <0.05 as statistically significant difference.
结果result
两组患者经两种不同方法治疗后,随访1年,结果显示,治疗组的疗效显著优于对照组,差异有统计学意义(P<0.05),见表1。After two groups of patients were treated with two different methods, followed up for 1 year, the results showed that the curative effect of the treatment group was significantly better than that of the control group, and the difference was statistically significant (P<0.05), as shown in Table 1.
表1两组疗效比较Table 1 Comparison of curative effects between the two groups
所有上述的首要实施这一知识产权,并没有设定限制其他形式的实施这种新产品和/或新方法。本领域技术人员将利用这一重要信息,上述内容修改,以实现类似的执行情况。但是,所有修改或改造基于本发明新产品属于保留的权利。All of the above-mentioned primary implementations of this intellectual property rights are not intended to limit other forms of implementations of this new product and/or new method. Those skilled in the art will, with this important information, modify the above to achieve a similar implementation. However, all modifications or alterations to the new product based on the present invention belong to reserved rights.
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例。但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。The above is only a preferred embodiment of the present invention, and is not intended to limit the present invention to other forms. Any skilled person who is familiar with this profession may use the technical content disclosed above to change or modify the equivalent of equivalent changes. Example. However, any simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention still belong to the protection scope of the technical solution of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410080380.4A CN103876352B (en) | 2014-03-06 | 2014-03-06 | Knee braces for knee arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410080380.4A CN103876352B (en) | 2014-03-06 | 2014-03-06 | Knee braces for knee arthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103876352A CN103876352A (en) | 2014-06-25 |
CN103876352B true CN103876352B (en) | 2015-06-24 |
Family
ID=50945733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410080380.4A Expired - Fee Related CN103876352B (en) | 2014-03-06 | 2014-03-06 | Knee braces for knee arthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103876352B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104188178A (en) * | 2014-09-14 | 2014-12-10 | 吴世阔 | Healthcare knee pad and preparation method thereof |
CN106924665A (en) * | 2017-03-30 | 2017-07-07 | 青岛大学附属医院 | A kind of medical knee-pad of hot compress |
CN107549894A (en) * | 2017-10-26 | 2018-01-09 | 张喜 | A kind of device for aiding in alleviating arthralgia |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2279928Y (en) * | 1997-02-12 | 1998-04-29 | 王国欣 | Health-care bed mattress |
CN1350852A (en) * | 2000-10-30 | 2002-05-29 | 兰州三极生物资源技术公司 | Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout |
CN1531950A (en) * | 2003-03-18 | 2004-09-29 | 李章雄 | Plaster medicine composition with multiple purpose for treating affection pain due to dampness |
CN2714016Y (en) * | 2004-06-28 | 2005-08-03 | 新疆天地集团有限公司 | Heat treatment kneepad |
CN1730082A (en) * | 2005-08-01 | 2006-02-08 | 王世杰 | Powder for curing pains of muscles and bones |
CN101485830A (en) * | 2009-02-19 | 2009-07-22 | 宋小冰 | Pure Chinese medicine anti-aging health-care capsule |
CN101905007A (en) * | 2010-07-09 | 2010-12-08 | 徐利华 | Plaster for curing rheumatoid pains in neck, shoulders, waist and legs |
CN101912575A (en) * | 2010-08-03 | 2010-12-15 | 彭树林 | External medicament for treating painful swelling of joints and gout diseases and preparation process thereof |
-
2014
- 2014-03-06 CN CN201410080380.4A patent/CN103876352B/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2279928Y (en) * | 1997-02-12 | 1998-04-29 | 王国欣 | Health-care bed mattress |
CN1350852A (en) * | 2000-10-30 | 2002-05-29 | 兰州三极生物资源技术公司 | Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout |
CN1531950A (en) * | 2003-03-18 | 2004-09-29 | 李章雄 | Plaster medicine composition with multiple purpose for treating affection pain due to dampness |
CN2714016Y (en) * | 2004-06-28 | 2005-08-03 | 新疆天地集团有限公司 | Heat treatment kneepad |
CN1730082A (en) * | 2005-08-01 | 2006-02-08 | 王世杰 | Powder for curing pains of muscles and bones |
CN101485830A (en) * | 2009-02-19 | 2009-07-22 | 宋小冰 | Pure Chinese medicine anti-aging health-care capsule |
CN101905007A (en) * | 2010-07-09 | 2010-12-08 | 徐利华 | Plaster for curing rheumatoid pains in neck, shoulders, waist and legs |
CN101912575A (en) * | 2010-08-03 | 2010-12-15 | 彭树林 | External medicament for treating painful swelling of joints and gout diseases and preparation process thereof |
Non-Patent Citations (4)
Title |
---|
刘自力.鹿衔草.《救世良方文献研究》.云南名族出版社,2007,第213页. * |
四川省绵阳地区卫生局.四、化痰止咳药类.《常用中草药单验方汇编》.1971,第294-296页. * |
河南省卫生厅.卷柏(垫状卷柏).《河南省中药材标准》.中原农民出版社,1992,第62-63页. * |
陈桂喜.第十二章 活血祛瘀药.《传统中药经验精粹》.湖南科学技术出版社,2004,第231页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103876352A (en) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
CN103463241A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
CN103876352B (en) | Knee braces for knee arthritis | |
CN103784890A (en) | Traditional Chinese medicine composition for treating bone diseases | |
CN114452347A (en) | A composition for treating pain in neck, shoulder, waist and leg, and prolapse of lumbar intervertebral disc, and its preparation method | |
CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
CN101961400B (en) | Chinese medicament for treating sciatica and preparation method and application thereof | |
CN106963923A (en) | A kind of Chinese medicine composition and preparation method and application with analgesic activity | |
CN104825563B (en) | A kind of Chinese medicine preparation treating cervical spondylosis and preparation method thereof | |
CN104706749B (en) | A kind of Chinese medicine composition for treating lumbar vertebrae shoulder disc protrusion | |
CN102302571B (en) | Chinese medicinal composition for treating bony spur diseases and preparation method and application thereof | |
CN107998235B (en) | Compound Zhuang medicine for treating ankle sprain and preparation method thereof | |
CN100446808C (en) | Medicine for treating cold after delivery | |
CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
CN105497824A (en) | Traditional Chinese medicine composition for treating calcaneodynia | |
CN110025759A (en) | The Chinese medicine composition and preparation method thereof for treating cervical vertebra, lumbar vertebrae and arthropathy | |
CN116327852B (en) | Plaster for treating osteoarthritis and preparation method thereof | |
CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
CN115737730B (en) | Traditional Chinese medicine composition for treating plantar fasciitis and preparation method thereof | |
CN116942740B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and application thereof | |
CN115645503B (en) | Pharmaceutical composition and acupoint application ointment for chronic pain diseases | |
CN115137801B (en) | Traditional Chinese medicine composition for treating cervical spondylosis, acupoint plaster, and preparation method and application thereof | |
CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
CN101904922B (en) | Plaster for treating pain caused by femoral head necrosis | |
CN106924665A (en) | A kind of medical knee-pad of hot compress |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Fachang Inventor after: Hua Wei Inventor after: Wu Liang Inventor after: Wang Fawen Inventor after: Liu Jia Inventor before: Wang Fachang Inventor before: Guan Tao Inventor before: Lin Bo Inventor before: Wang Jinzhuang Inventor before: Yan Tingting |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG FACHANG GUAN TAO LIN BO WANG JINZHUANG YAN TINGTING TO: WANG FACHANG HUA WEI WU LIANG WANG FAWEN LIU JIA |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150624 Termination date: 20160306 |
|
CF01 | Termination of patent right due to non-payment of annual fee |